Scientists at the University of Birmingham have developed a powerful new breakthrough lab model that could speed up the search for treatments for an aggressive blood cancer, according to research published in Nature Communications. The team focused on myelodysplastic syndrome (MDS), a blood cancer that affects about 4 in 100,000 people each year. MDS often progresses to acute myeloid leukemia (AML), a far more dangerous condition with poor survival rates. In this groundbreaking study, researchers created a “true-to-life” model using induced pluripotent stem cells from actual MDS patients. These special cells can be reprogrammed to develop into different cell types, … Continue reading Blood Cancer Research Confirms CEBPA Gene Mutation Cuts Survival from 31 to 15 Months in MDS-AML Progression